(Stroke. 2000;31:1702.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Midwest Neurology Group, Evensville, Mo (R.P.P.); General Electrical Inc, Bangalone, India (R.V.); the Department of Neurology, Washington University, St Louis, Mo (M.N.D., Y.Y.H., C.Y.H.); and the Department of Radiology and Biomedical Engineering, University of North Carolina at Chapel Hill (W.L.).
Correspondence to Weili Lin, PhD, Department of Radiology, University of North Carolina at Chapel Hill, CB# 7515, Chapel Hill, NC 27599. E-mail weili_lin{at}med.unc.edu
| Abstract |
|---|
|
|
|---|
MethodsA suture model was used to induce focal cerebral ischemia for 90 minutes (n=44). The rats were randomly assigned to 3 groups 2.5 hours after reperfusion: dehydration (n=24), control (n=8), or hydration (n=12). BW was obtained with the wet-dry weight method 24 hours after middle cerebral artery (MCA) occlusion. In addition, MRI were obtained (n=31) 24 hours after the onset of ischemia so that the ratio of hemispheric volumes ipsilateral (IH) and contralateral (CH) to the infarct and the extent of MLS could be obtained.
ResultsAcross the range from moderate dehydration to intravascular volume expansion with isotonic saline, BW of the IH increased linearly as a function of change in body weight (r2=0.89), whereas few changes in relation to body weight were observed in CH, indicating a preferential effect of fluid management on the infarcted hemisphere. Furthermore, the hemispheric volume ratio (IH/CH) and MLS also increased in relation to changes in body weight. However, paradoxical increases in BW, IH/CH, and extent of MLS were observed in comparison with controls when severe dehydration was produced with high-dose mannitol.
ConclusionsChanges in ischemic BW by fluid management correlated closely with changes in body weight except when high-dose mannitol was used. Mannitol, as a dehydrating agent, may be associated with bimodal effects, with a high dose aggravating ischemic BW.
Key Words: brain edema cerebral ischemia magnetic resonance imaging rats
| Introduction |
|---|
|
|
|---|
Using a rat model of ischemic cortical infarction, we recently demonstrated that multiple-dose mannitol infusions consistently increased plasma osmolality, produced total body dehydration, and reduced the water content of brain tissue. In experiments producing mild to moderate dehydration, brain tissue water content was decreased to a greater extent in the hemisphere ipsilateral to the infarct (IH) than in the contralateral hemisphere (CH), suggesting a potentially favorable effect of mannitol on cerebral tissue shifts.24 We postulated that the reduction of the water content of the infarcted hemisphere was caused by the general diuretic effect of mannitol (through reduction of interstitial fluid volume),29 although alternative explanations relating the rheological and free radicalscavenging effects of mannitol to the severity of the primary ischemic insult are also plausible.33 34 The goal of the present study was to assess the influence of fluid management reflected by changes in body weight on the extent of ischemic brain edema after a uniform cerebral insult produced by focal cerebral ischemia-reperfusion. In addition, we also assess the degree of MLS as an adjunct end point of fluid management. For these purposes, we used a rat model of ischemic infarction that simulates many of the clinically relevant features of LHI35 and an MRI protocol that was sensitive to subtle changes in MLS. Although there are numerous experimental approaches to osmotic manipulation of potential interest in the management of ischemic stroke,16 17 18 19 20 21 22 23 24 31 32 we chose to compare the natural history of edema formation in this model with the effects of volume expansion with crystalloid (isotonic saline) and dehydration with the diuretics furosemide and mannitol because of the widespread use of these agents clinically.
| Materials and Methods |
|---|
|
|
|---|
Fluid Management Protocols
After recovery from general anesthesia (return of
righting reflexes), animals were randomly assigned to either
dehydration (n=24), control (ad lib; n=8), or hydration protocols
(n=12). All infusions (saline, mannitol, and furosemide) were
administered via indwelling intravenous catheters at a
constant rate of 0.5 to 0.75 mL/min through a Sage microinfusion pump.
Rats randomized to the dehydration group were divided into 1 of 3
subgroups: intravenous infusions of a 25%
mannitol solution every 5 hours (250 mg/mL, 1372 mOsm/L, Abbott
Laboratories) at either a high dose (1.5 g/kg; mannitol HD; n=8), or a
low dose (0.5 g/kg; mannitol LD; n=9) or intravenous
infusions of furosemide at a single dose every 5 hours (0.5 mg/kg;
n=7). In each case, the first dose of diuretic agent was given
2.5 hours after reperfusion of the right MCA; a 0.5-mL bolus of
isotonic saline was injected after each intravenous
infusion to maintain the patency of the catheters. Mannitol-treated and
furosemide-treated rats had free access to food but were restricted
from drinking water or other fluids during the 24-hour experimental
period. Preliminary experiments (data not shown) established the
typical changes in total body weight expected from sustained
administration of mannitol and furosemide at these doses and indicated
that these agents were generally well tolerated and did not produce
significant changes in arterial blood pressure. Control
group rats (n=8) received 0.5-mL boluses of isotonic saline via
indwelling intravenous catheters every 5 hours, also
beginning 2.5 hours after MCA reperfusion, but were otherwise under ad
lib conditions. The rats in the hydration group were divided into 2
subgroups, the first group receiving enough isotonic saline every 5
hours to maintain constant body weight ±1% with respect to
baseline (preischemia) (saline A; n=7) and the second group
receiving enough isotonic saline every 5 hours to increase body weight
5% above the baseline value (saline B; n=5). Hydration group rats
had free access to food but were restricted from drinking water.
MRI Protocol
Twenty-four hours after induction of the ischemic
insult, 31 of the 44 rats were reanesthetized (pentobarbital,
65 mg/kg IP) for MR brain imaging. Their heads were placed within a
cylindrical MR-compatible frame that maintained a constant orientation
between the sagittal plane of the cerebrum and the long axis of a
custom-made receive-only radiofrequency coil. In this way, the anatomic
regions corresponding to the third ventricle from which measurements of
MLS were made could be positioned optimally within the coil in each
case. A 3D gradient echo FLASH (fast low
angle shot) sequence with radiofrequency spoiling
was used to acquire T1-weighted images of the
brain with a 1.5-T Siemens Vision MRI system (Siemens Medical
Systems). Imaging parameters were as follows:
repetition time=25 ms; echo time=8 ms; flip
angle=40°; matrix size=64x64 interpolated to
128x128; field of view 55 mm2; and 32
partitions with slice thickness of 1 mm.
Quantification of Plasma Osmolality and Cerebral Edema
All animals were killed immediately after the imaging session to
maintain a consistent relationship between the end point of the
fluid management protocol, MRI, and the ex vivo measurement of brain
tissue water. To obtain blood samples and discern possible
hemodynamic changes caused by the hydration or
dehydration, a femoral arterial catheter was placed with
the rat under pentobarbital anesthesia (65 mg/kg IP)
immediately before the end of the experiment. Mean arterial
blood pressure (MABP) was measured for 5 minutes with the use of a
Micro-Med transducing system (Micro-Med, Inc), and the average value
was recorded. A sample of blood was processed for determination of
hematocrit and plasma osmolality (mOsm/L) with a
microcentrifuge and an automated freezing point depression
micro-osmometer (Advanced Instruments, Inc), respectively. At the end
of the experiment, each animal was weighed within 1 g for
comparison with its initial (preischemia) body weight.
Brain water was quantitated by the wet-dry weight method as described previously.37 Briefly, animals were killed by decapitation under deep pentobarbital anesthesia, the brain was removed, and the cerebral convexities were exposed in a humidified chamber. The olfactory projections and frontal poles of the brain were resected and discarded; the remainder of the forebrain was isolated from the brain stem at the level of the superior colliculus and then separated into halves by severing the corpus callosum. Each hemisphere was gently blotted with tissue paper to remove small quantities of adsorbent cerebrospinal fluid. Tissue samples were rapidly weighed with a basic precision scale (Saltorius 2462, Saltorius Werke) to within 0.1 mg and dried to constant weight in a vacuum oven (Precision Scientific) at 80°C and low vacuum. The percent H2O of each tissue sample was then calculated according to the following equation: %H2O=(Wet Weight-Dry Weight)/Wet Weightx100.38
Data Analysis
MLS apparent on MR images was quantitated according to
adaptations of the general criteria used in the imaging studies of
Ropper et al39 40 involving humans with
supratentorial mass lesions. Coronal images from
the centroparietal slices of the rat brain were chosen because they
permit unambiguous measurement of tissue shifts with respect to the
third ventricle, a readily identified anatomic landmark. In all rats,
centroparietal slices in which the third ventricle could be identified
as a distinct structure were used for measurement of MLS according to
the following procedure. First, with automated image processing
software (DIP Station, Hayden Image Processing Group), a horizontal
score line was drawn by connecting tangents to the inferior
aspects of each temporal lobe. Perpendicular lines from this horizontal
base that were tangent to the right and left parietal convexities were
then inscribed to form a rectangular framework unique to each coronal
slice. Perpendicular projections from the parietal convexities to
the center of the third ventricle were then inscribed on each image.
MLS of the third ventricle was defined as the ratio of the distances
from the parietal convexity to the center of the third ventricle for
the IH and CH, respectively.
Nonideal slice profile could potentially interfere with the identification of the contours of brain hemispheres on MR images obtained from the anterior and posterior extremes of the imaging coil. Therefore, the data set used for both MLS and volume determinations was limited to the central 10 slices. The areas of the IH and CH within each of these coronal slices were assessed by a single blinded participant who had no information as to which groups that the rats were assigned to. For the medial-most segments of the cerebral hemispheres, borders were defined by the aforementioned score lines between the third ventricle and midline structures at the base of the skull. In coronal slices anterior and posterior to the region of the third ventricle, the medial borders of each hemisphere were defined by connecting the superior and inferior longitudinal fissures. The areas within these contours were automatically determined with the DIP Station software, and the volumes of the IH and CH were then determined by summation of the elements from 10 contiguous coronal slices.
Statistical Analysis
Statistical analysis was performed between control,
dehydrated, and hydrated groups and their respective subgroups.
Differences between measured parameters (% change total
body weight, measured plasma osmolality, MABP, and
%H2O of the IH and CH) were tested for
significance with ANOVA. The significance level between groups was
assessed with post hoc Tukey tests. MRI-derived parameters
(calculated hemispheric volumes and MLS) were also assessed for
significance with ANOVA and the post hoc Tukey test. A value of
P<0.05 was considered significant. In addition, correlation
coefficients (r2) were derived from
linear regression analyses of the relationships between
percentage change in total body weight and %H2O
of both CH and IH. In the case of the IH, this analysis was
performed separately for percentage change in body weight above and
below the cutoff value of 92.5%, which is the inflection point of a
V-shaped regression curve plotting %H2O versus
body weight (see Figure 1
).
|
| Results |
|---|
|
|
|---|
|
Repeated infusions of high-dose mannitol over 24 hours produced significant increases in plasma osmolality and hematocrit in comparison with controls (P<0.01), indicating that rats receiving high-dose mannitol had more pronounced hyperosmolality and hemoconcentration than those receiving low-dose mannitol. In contrast, there were no statistically significant differences in plasma osmolality between controls and rats in the furosemide subgroup or either of the hydration subgroups. Hematocrit values were significantly increased in the furosemide subgroup (P<0.05) and decreased (P<0.05) in the hydration subgroups, respectively. Although there was a trend toward lower MABP in rats treated with furosemide, none of the fluid management protocols produced significant changes in MABP as measured 24 hours after ischemia in comparison with controls.
Impact of Fluid Management on Water Content of Cerebral
Hemispheres
When %H2O in the IH was related to the
changes in total body weight resulting from fluid management (ie,
decreased by dehydration, decreased mildly in ad lib, maintained or
increased by hydration), a distinctly bimodal relationship could be
discerned with an inflection point corresponding to an
10%
reduction in body weight (Figure 1
). Across the range of values
to the right of this inflection point (including rats with moderate
dehydration by either low-dose mannitol or furosemide, ad lib controls,
and hydration group rats), %H2O in the IH
increased linearly (r2=0.89) as a
function of increase in body weight. Across the range of values to the
left of this inflection point, %H2O in the IH
also increased in a linear fashion
(r2=0.83) in relation to severe
dehydration. The percent H2O in the CH increased
only modestly in relation to increases in total body weight and did not
exhibit a bimodal distribution.
IH/CH Volume Ratios
Hemispheric volumes were calculated from MR images, and the ratios
of the volumes of the IH to those of the CH were generated as an index
of cerebral volume asymmetry, as shown in Figure 2
. The IH/CH ratios in the low-dose
mannitol and furosemide-treated subgroups were both lower than those of
controls, but the differences reached statistical significance only in
the low-dose mannitol subgroup (P<0.05). In contrast,
significant increases in the IH/CH ratio in comparison with control
values were observed at both extremes of fluid management (high-dose
mannitolinduced dehydration, P<0.05, and hydration with
isotonic saline, P<0.01). These results are congruent with
the %H2O data presented above.
|
Impact of Hydration Status on MLS
A comparison of MLS between different groups is shown in Figure 3
. As expected, the IH/CH volume ratio
and the extent of MLS were well correlated
(r2=0.89). In comparison with the
control group, MLS was less in both the furosemide-treated and low-dose
mannitoltreated subgroups, and this difference reached statistical
significance in the latter (P<0.05). In contrast, MLS was
significantly greater for rats in both hydration subgroups
(P<0.05) and the high-dose mannitol subgroup
(P<0.05) of the study. Again, the latter was associated
with the most severe total body dehydration.
|
| Discussion |
|---|
|
|
|---|
Although indirect evidence can be found,44 45 to our knowledge, there are no data available that specifically relate total body hydration status to the extent of brain edema after a focal cerebral ischemic insult. Our findings indicate decreased water content in the IH in moderately dehydrated rats in comparison with controls and increased %H2O in the IH in rats subjected to isotonic intravascular volume expansion. The paradoxical effect of high-dose mannitol on BW and MLS is addressed below. Although the experiments presented here were not designed to specifically address the mechanisms by which edema fluid distributes within the brain, the most likely explanation of our results would be a shift in Starling forces to favor the isotonic movement of plasma water across the damaged cerebral vasculature. Either a reduction of plasma oncotic forces (secondary to hemodilution) or increases in mean intraluminal pressure or a combination of these effects could account for the increased movement of intravascular fluid into the brains interstitial space. The volume of the vasogenic component of ischemic brain edema would, according to this concept, rise and fall in parallel with expansion or contraction of the bodys interstitial fluid volume. The superimposition of a relatively large increase in the water content of the IH in comparison with that of the CH is consistent with the notion that the BW is more resistant to changes in plasma osmolarity or total body hydration status across an intact blood-brain barrier (BBB). The lack of changes in %H2O in CH is likely to contribute to a greater IH/CH volume ratios and MLS in hydrated rats.
Several investigators have reported little or no change in BW or tissue
volume in experiments involving models of vasogenic brain edema in
which animals were subjected to vigorous hydration with fluids of
various composition, including isotonic saline solutions. The
discrepancy between these results and our data may be explained by
intrinsic differences in the animals models used to produce BBB
breakdown or differences in the composition of the fluids used but more
likely by the duration and/or intensity of hydration.46 47
For example, the negative findings in a study involving isotonic
hydration in a model of transient global cerebral
ischemia47 may be explained by the known
differences in the pathophysiology of global and focal brain
ischemia at the level of injury to the cerebral vasculature and
BBB.48 49 The relative preservation of BBB integrity after
normothermic global ischemia would be expected to
minimize vasogenic edema formation in response to hydration. In the
present study, the body weights of each rat were measured
repeatedly in the hydration group over the course of the 24-hour
experiment, and adjustments were made in fluid infusion rates to
achieve predetermined goals of
100% and 105% of the baseline body
weight by the end of each experiment. The weight change data
presented in the Table
indicate that these goals were
achieved.
The apparent bimodal effect of mannitol on ischemic edema indicates a more complex interaction between mannitol-induced dehydration or other effects of this agent and changes in tissue volume. Consistent with the results of a previous study,24 moderate dehydration produced by a series of low-dose infusions of a 25% mannitol solution (0.5 g/kg every 5 hours) was associated with statistically significant reduction in %H2O and IH/CH volume ratio in comparison with controls and significantly less MLS. A nearly equivalent degree of total body dehydration brought about by repeated infusions of intravenous furosemide (at a dose previously shown not to produce significant acute changes in MABP) was associated with modest elevations of hematocrit and a trend toward a decrease in %H2O in the IH in comparison with controls that did not reach statistical significance. Low-dose mannitol resulted in a somewhat greater reduction in the %H2O of the IH than furosemide, although there were no statistically significant differences between these dehydration subgroups. The comparable effects of moderate dehydration induced with either furosemide or low-dose mannitol lend support to the notion that the reduction of water content of the IH associated with these agents may simply reflect their impact on total body water through a common diuretic action.
In contrast, when a much larger dose of mannitol (1.5 g/kg) was infused
at the same frequency, weight loss was severe, mean plasma osmolality
increased by
30 mOsm/L above control levels, and
%H2O, IH/CH volume ratio, and MLS were
significantly increased in comparison with control rats. The
paradoxical results from the high-dose mannitol subgroup suggest that a
potentially beneficial effect of osmotic diuresis on the volume
of ischemic edema may be obtained only when mild to moderate
degrees of dehydration are produced. Beyond that level, countervailing
processes associated with mannitol infusions may result in an actual
increase in brain edema. Although these experiments were not designed
to identify the mechanism(s) by which mannitol-induced dehydration
could increase brain edema, our observations are consistent
with the explanation postulated by other investigators that exogenous
osmoles may accumulate within damaged tissue and thereby produce an
increase in BW through the establishment of a "reverse" osmotic
gradient.22 This process would seem more likely to occur
under conditions of severe dehydration in which renal clearance of
mannitol would be impaired, resulting in its accumulation within plasma
and therefore in brain. Another possibility is that the adverse effects
of severe dehydration on blood rheology or arterial blood
pressure may have compromised cerebral blood flow to marginally
perfused tissues, resulting in a larger infarction. However, even in
association with high-dose mannitol infusions there were no significant
reductions in MABP noted in this series or in preliminary work.
Finally, as pointed out by Fishman and colleagues,50 51
the induction of "idiogenic osmoles" within the brain parenchyma in
association with high-dose mannitol infusions could cause cell swelling
and thereby an increase in brain water. To further investigate the
paradoxical effects of high-dose mannitol, an assessment of cerebral
blood flow may be useful in our understanding of the biphasic effects
of mannitol on brain edema.
The results of this study ultimately must be placed in the context of the clinical pathophysiology of ischemic brain edema. However, the limited spatial resolution of the MR images of the rat brain available for this study precluded analysis of axial displacements of brain structures in relation to the tentorium; our study was therefore limited to an analysis of the influence of simulated clinical fluid management on the position of the third ventricle relative to its normal midline position. It is recognized that the unique craniocerebral anatomy of the rat limits the scope of the conclusions that can be drawn from this study regarding changes in MLS observed in clinical situations. Furthermore, obvious differences in the water metabolism of humans and rodents preclude an extrapolation of our data on body weight change to what may be considered clinically relevant in the fluid management of clinical stroke. Nevertheless, these data support the basic concept that fluid balance during the evolution of a cerebral infarct may influence the volume of edema and the associated distortions of intracranial geometry. Mild to moderate dehydration with low doses of mannitol or furosemide produced "optimal" results, neither of which, however, were strikingly different from ad lib conditions. Increases in edema volume and frank worsening of MLS were observed at both extremes of the hydration-dehydration spectrum.
| Acknowledgments |
|---|
Received December 14, 1999; revision received February 22, 2000; accepted April 11, 2000.
| References |
|---|
|
|
|---|
2.
Halsey JH Jr, Capra NF. The course of experimental
cerebral infarction: the development of increased intracranial
pressure. Stroke. 1972;3:268278.
3.
Hacke W, Schwab S, Horn M, Spranger M, de Georiga M,
von Kummer R. "Malignant" middle cerebral artery territory
infarction: clinical course and prognostic signs. Arch
Neurol. 1996;53:309315.
4. Berrouschot J, Sterker M, Bettin S, Koster J, Schneider D. Mortality of space-occupying ("malignant") middle cerebral artery infarction under conservative intensive care. Intensive Care Med. 1998;24:620623.[Medline] [Order article via Infotrieve]
5.
Moulin T, Cattin F, Crepin-Leblond T, Tatu L; Chavot
D, Piotin M, Viel JF, Rumbach L, Bonneville JF. Early CT signs in acute
middle cerebral artery infarction: predictive value for subsequent
infarct locations and outcome. Neurology. 1996;47:366375.
6. Yoshimoto T, Ogawa A, Seki H, Kogure T, Suzuki J. Clinical course of acute middle cerebral artery occlusion. J Neurosurg. 1986;65:326330.[Medline] [Order article via Infotrieve]
7.
Heinsius T, Bogousslavsky J, Van Melle G. Large
infarcts in the middle cerebral artery territory: etiology and outcome
patterns. Neurology. 1998;50:341350.
8.
Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte
PN, Thron A. Type and extent of hemispheric brain infarctions and
clinical outcome in early and delayed middle cerebral artery
recanalization. Neurology. 1992;42:289298.
9. Wijdicks EF, Diringer MN. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc. 1998;73:829836.[Abstract]
10.
Chan PH, Fishman RA. Brain edema: induction in cortical
slices by polyunsaturated fatty acids. Science. 1978;201:358360.
11. Hatashita S, Hoff JT, Salamat SM. Ischemic brain edema and the osmotic gradient between blood and brain. J Cereb Blood Flow Metab. 1988;8:552559.[Medline] [Order article via Infotrieve]
12. Hsu CY, Liu TH, Xu J, Hogan EL, Chao J. Lipid inflammatory mediators in ischemic brain edema and injury. In: Bazan N, ed. Lipid Mediators in Ischemic Brain Damage and Experimental Epilepsy. Basel, Switzerland: Karger; 1990:85112.
13.
Yang GY, Chen SF, Kinouchi H, Chan PH, Weinstein PR.
Edema, cation content, and ATPase activity after middle cerebral artery
occlusion in rats. Stroke. 1992;23:13311336.
14.
Delashaw JB, Broaddus WC, Kassell NF, Haley EC,
Pendleton GA, Vollmer DG, Maggio WW, Grady MS. Treatment of right
hemispheric cerebral infarction by hemicraniectomy. Stroke. 1990;21:874881.
15. Carter BS, Ogilvy CS, Candia GJ, Rosas HD, Buonanno F. One-year outcome after decompressive surgery for massive nondominant hemispheric infarction. Neurosurgery.. 1997;40:11681175; discussion 11751176.[Medline] [Order article via Infotrieve]
16.
Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH,
Jansen O, Hacke W. Early hemicraniectomy in patients with complete
middle cerebral artery infarction. Stroke. 1998;29:18881893.
17. Warner DS, Boehland LA. Effects of iso-osmolal intravenous fluid therapy on post-ischemic brain water content in the rat. Anesthesiology. 1988;68:8691.[Medline] [Order article via Infotrieve]
18. Drummond JC, Patel PM, Cole DJ, Kelly PJ. The effect of the reduction of colloid oncotic pressure, with and without reduction of osmolality, on post-traumatic cerebral edema. Anesthesiology. 1998;88:9931002.[Medline] [Order article via Infotrieve]
19.
Hakamata Y, Ito U, Hanyu S, Yoshida M. Long-term
high-colloid oncotic therapy for ischemic brain edema in
gerbils. Stroke. 1995;26:2149153.
20. Belayev L, Busto R, Zhao W, Clemens JA, Ginsberg MD. Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats. J Neurosurg. 1997;87:595601.[Medline] [Order article via Infotrieve]
21. Matsui T, Sinyama H, Asano T. Beneficial effect of prolonged administration of albumin on ischemic cerebral edema and infarction after occlusion of middle cerebral artery in rats. Neurosurgery. 1993;33:293300.[Medline] [Order article via Infotrieve]
22. Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg. 1992;77:584589.[Medline] [Order article via Infotrieve]
23. Karibe H, Zarow GJ, Weinstein PR. Use of mild intraischemic hypothermia versus mannitol to reduce infarct size after temporary middle cerebral artery occlusion in rats. J Neurosurg. 1995;83:9398.[Medline] [Order article via Infotrieve]
24.
Paczynski RP, He YY, Diringer MN, Hsu CY. Multiple-dose
mannitol reduces brain water content in a rat model of cortical
infarction. Stroke. 1997;28:14371443.
25.
Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W.
Effects of hypertonic saline hydroxyethyl starch solution and mannitol
in patients with increased intracranial pressure after stroke.
Stroke. 1998;29:15501555.
26.
Manno EM, Adams RE, Derdeyn CP, Powers WJ, Diringer MN.
The effects of mannitol on cerebral edema after large hemispheric
cerebral infarct. Neurology. 1999;52:583587.
27. Reichenthal E, Kaspi T, Cohen ML, Shevach I, Shalmon E, Bar-Ziv Y, Feldman Z, Zucker G. The ambivalent effects of early and late administration of mannitol in cold-induced brain oedema. Acta Neurochir Suppl (Wien). 1990;51:110112.[Medline] [Order article via Infotrieve]
28. Classen RA, Cooke PM, Pandofi S, Carnecki G, Bryar G. Hypertonic urea in experimental cerebral edema. Arch Neurol. 1965;12:424434.
29. Pappius HM, Dayes LA. Hypertonic urea: its effect on the distribution of water and electrolytes in normal and edematous brain tissues. Arch Neurol. 1965;13:395402.
30.
Frank JI. Large hemispheric infarction, deterioration,
and intracranial pressure. Neurology. 1995;45:12861290.
31. Pereira BM, Weinstein PR, Rodriguez y Baena R. Effect of treatment with fluosol and mannitol during temporary middle cerebral artery occlusion in cats. Neurosurgery. 1988;23:139142.[Medline] [Order article via Infotrieve]
32. Go KG, de Lange WE, Sluiter WJ, van Woudenberg F, Ebels EJ, Blaauw EH. The influence of salt-free solutions on cold-induced cerebral oedema: a chemical and morphological study in the rat. J Neurol Sci. 1973;18:323333.[Medline] [Order article via Infotrieve]
33.
Malek AM, Goss GG, Jiang L, Izumo S, Alper SL. Mannitol
at clinical concentration activates multiple signaling pathways
and induces apoptosis in endothelial cells.
Stroke. 1998;29:26312640.
34.
Suzuki J, Imaizumi S, Kayama T, Yoshimoto T.
Chemiluminescence in hypoxic brain: the second report: cerebral
protective effect of mannitol, vitamin E, glucocorticoid.
Stroke. 1995;16:695700.
35.
Longa EZ, Weinstein PR, Carlson S, Cummins R.
Reversible middle cerebral artery occlusion without craniectomy in
rats. Stroke. 1989;20:8491.
36.
Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD.
Middle cerebral artery occlusion in the rat by intraluminal suture:
neurological and pathological evaluation of an improved model.
Stroke. 1996;27:16161622.
37.
Lin TN, He YY, Wu G, Khan M, Hsu CY. Effect of brain
edema on infarct volume in a focal cerebral ischemia model in
rats. Stroke. 1993;24:117121.
38. Elliott KA, Jasper H. Measurement of experimentally induced brain swelling and shrinkage. Am J Physiol. 1949;157:122129.
39. Ropper AH. Lateral displacement of the brain the level of consciousness in patients with an acute hemisphere mass. N Engl J Med. 1986;314:953958.[Abstract]
40.
Ropper AH. A preliminary MRI study of the geometry of
brain displacement and level of consciousness with acute intracranial
masses. Neurology. 1989;39:622627.
41.
Mchedlishvili GI, Kapuscinski A, Nikolaishvili L.
Mechanisms of postischemic brain edema: contribution of
circulatory factors. Stroke. 1976;7:410416.
42. Hatashita S, Hoff JT. Cortical tissue pressure gradients in early ischemic brain edema. J Cereb Blood Flow Metab. 1986;6:17.[Medline] [Order article via Infotrieve]
43. Reulen HJ, Graham R, Spatz M, Klatzo I. Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema. J Neurosurg. 1977;46:2435.[Medline] [Order article via Infotrieve]
44. Albright AL, Latchaw RE, Robinson AG. Intracranial and systemic effects of osmotic and oncotic therapy in experimental cerebral edema. J Neurosurg. 1984;60:481489.[Medline] [Order article via Infotrieve]
45. James HE, Schneider S. Effects of acute isotonic saline administration on serum osmolality, serum electrolytes, brain water content and intracranial pressure. Acta Neurochir Suppl (Wien). 1993;57:8993.[Medline] [Order article via Infotrieve]
46. Shapira Y, Artru AA, Cotev S, Muggia-Sulam M, Freund HR. Brain edema and neurologic status following head trauma in the rat: no effect from large volumes of isotonic or hypertonic intravenous fluids, with or without glucose. Anesthesiology. 1992;77:7985.[Medline] [Order article via Infotrieve]
47. Rubin JR, Labadie E, Anderson G, Persky J, Goldstone J. Effect of hemodilution on brain tissue during global ischemia. Ann Vasc Surg. 1988;2:127132.[Medline] [Order article via Infotrieve]
48. Hossmann KA. Development and resolution ischemic brain swelling. In: Pappius HM, Feindel W, eds. Dynamics of Brain Edema. Berlin, Germany: Springer-Verlag; 1976:219227.
49. Klatzo I, Suzuki R, Orzi F, Schuier F, Nitsch C. Pathomechanisms of ischemic brain edema. In: Go KG, Baethmann A, eds. Recent Progress in the Study and Therapy of Brain Edema. New York, NY: Plenum Press; 1982:110.
50. Chan PH, Fishman RA. Elevation of rat brain amino acids, ammonia and idiogenic osmoles induced by hyperosmolality. Brain Res. 1979;161:293301.[Medline] [Order article via Infotrieve]
51. Fishman RA. Cerebrospinal Fluid in Diseases of the Nervous System. Philadelphia, Pa; WB Saunders Co; 1992.
Neurosurgical Laboratories Stanford University Palo Alto, California
| Introduction |
|---|
|
|
|---|
Received December 14, 1999; revision received February 22, 2000; accepted April 11, 2000.
| References |
|---|
|
|
|---|
2. Chan PH, Yang GY, Chen SF, Carlson E, Epstein CJ. Cold-induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn-superoxide dismutase. Ann Neurol.. 1991;29:482486.[Medline] [Order article via Infotrieve]
3. Chan PH, Fishman RA. Elevation of rat brain amino acids, ammonia and idiogenic osmoles induced by hyperosmolality. Brain Res.. 1979;161:293301.
4. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan PH, Verkman AS. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med.. 2000;6:159163.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
Y.-Y. Zheng, Y.-P. Lan, H.-F. Tang, and S.-M. Zhu Propofol Pretreatment Attenuates Aquaporin-4 Over-Expression and Alleviates Cerebral Edema After Transient Focal Brain Ischemia Reperfusion in Rats Anesth. Analg., December 1, 2008; 107(6): 2009 - 2016. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bardutzky and S. Schwab Antiedema Therapy in Ischemic Stroke Stroke, November 1, 2007; 38(11): 3084 - 3094. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |